ArticleFrontiers in medicine2025
The trends and future projections of intraocular foreign bodies among children and adolescents: a global analysis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim was to evaluate the disease burden of intraocular foreign bodies (IOFBs) among children and adolescents globally based on the Global Burden of Disease, Injury, and Risk Factor Study 2021 (GBD 2021). Methods: Data were extracted from the GBD 2021. The incidence and DALYs number and rate with 95% uncertainty interval (UI) and estimated annual percent change (EAPC) of IOFBs were estimated by age, sex and socio-demographic index (SDI) region. A Bayesian age-period-cohort (BAPC) analysis model was used to predict trends in the next ten years. Results: Globally, it is estimated that the incidence number of IOFBs among children and adolescents increased from 5842769.65 in 1990 to 6154651.76 in 2021, while the age-specific incidence rate decreased from 258.69 in 1990 to 233.50 in 2021, with a EAPC being -0.54. The 15-19 years group had the highest incidence and DALYs number, while 0-4 years group had the lowest. The projective model indicates that the burden for IOFBs will rise sharply in the next ten years. Conclusion: The global incidence and disease burden of blindness and vision loss in children and adolescents due to IOFB have shown a slight decline from 1990 to 2021. However, there may be a significant upward trend in the future, which requires the vigilant attention of policymakers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.